Abstract
The purpose of the present study was twofold. First, to determine the frequency of hyperlipidaemia after heart transplantation (Tx) in relation to values obtained before Tx. Secondly, to examine the effect of low-dose lovastatin on possible antiatherogenic mechanisms and test the hypothesis that the side-effects are dose-dependent. Retrospective study of the frequency of hyperlipidaemia disturbances in heart transplant patients. In addition, in a prospective study, the safety and efficacy of incremental low doses of lovastatin up to 20 mg day-1 were studied, with measurements of its plasma concentration in 24 cyclosporin A treated heart (n = 14) and kidney (n = 10) recipients with total cholesterol > 7.5 mmol L-1. Cholesterol increased markedly after heart transplantation from a pretransplant value of 5.3 (5.0,5.6) mmol L-1 to 6.7 (6.4,7.0) mmol L-1 after 1 year and then remained constant, but this increase was largely due to a 'normalization' since cholesterol decreased significantly during increasing heart failure before transplantation. Treatment with lovastatin decreased total cholesterol by 19% (P < 0.001), primarily by an effect on LDL cholesterol. HDL cholesterol increased by 15% (P < 0.05), whereas triglycerides remaine...Continue Reading
References
Oct 1, 1979·Annals of Internal Medicine·D C CattranS A Fenton
May 11, 1992·Journal of the American College of Cardiology·C M BallantyneA M Gotto
Jun 1, 1992·Clinical Cardiology·E J DiamantopoulosS D Moulopoulos
Jul 1, 1992·European Heart Journal·P F SmithJ S MacDonald
Dec 1, 1991·The Journal of Clinical Investigation·J L Witztum, D Steinberg
Oct 11, 1991·Journal of the American College of Cardiology·J A FarmerJ B Young
Jul 1, 1991·International Journal of Cardiology·H DaviesT English
Sep 15, 1991·The American Journal of Cardiology·Y ChancerelleJ F Kergonou
Nov 1, 1991·Archives of Biochemistry and Biophysics·R W WangK P Vyas
Nov 8, 1990·The New England Journal of Medicine·G BrownH T Dodge
Nov 1, 1990·The American Journal of Cardiology·L RudasW J Kostuk
Jun 14, 1990·The New England Journal of Medicine·J PekkanenH A Tyroler
Sep 15, 1989·The American Journal of Cardiology·P C KuoD E Vaughan
Nov 1, 1988·The American Journal of Cardiology·S Z GaoE B Stinson
Dec 1, 1988·The American Journal of Cardiology·J S StamlerJ Loscalzo
Aug 1, 1987·Transplantation·D M BeckerW A Baumgartner
Sep 4, 1987·JAMA : the Journal of the American Medical Association·W B KannelR B D'Agostino
Jan 20, 1984·JAMA : the Journal of the American Medical Association
Sep 7, 1995·The New England Journal of Medicine·J A KobashigawaG A Cogert
Aug 1, 1994·Journal of Epidemiology and Community Health·J E Berg, A T Høstmark
Mar 1, 1994·Circulation·D WatersJ Lespérance
Jun 1, 1993·Journal of the American Society of Nephrology : JASN·A K CheungM C Gregory
Jan 1, 1993·Biological Mass Spectrometry·M J MorrisW F Bayne
Jun 16, 1993·JAMA : the Journal of the American Medical Association
Citations
Mar 20, 2001·Current Atherosclerosis Reports·P M Moriarty, C A Gibson
Aug 24, 1999·Transplantation Proceedings·L GullestadS Simonsen
Sep 6, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·John C K LaiUNKNOWN Heart Stroke Foundation of British Columbia and Yukon, Program Project Grant Investigators
Feb 16, 2006·Transplantation·Dmitri SviridovAnthony Dart
Jul 9, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A AsbergH Holdaas
Sep 30, 2020·International Journal of Molecular Sciences·Yiting YangXiaodong Liu